|
|
Volumn 72, Issue 4, 2008, Pages 498-499
|
|
Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: Attractive concept, but limited evidence of benefit
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CREATINE KINASE MB;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
PLACEBO;
PROPRANOLOL;
TROPONIN T;
ANTITHROMBOCYTIC AGENT;
BIOLOGICAL MARKER;
FIBRINOGEN RECEPTOR;
ACUTE CORONARY SYNDROME;
CLINICAL TRIAL;
CORONARY ARTERY BLOOD FLOW;
CORONARY STENT;
CREATINE KINASE BLOOD LEVEL;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE OXYGEN CONSUMPTION;
HEART PROTECTION;
HUMAN;
MORBIDITY;
MORTALITY;
NOTE;
PERCUTANEOUS CORONARY INTERVENTION;
REFERENCE VALUE;
REPERFUSION INJURY;
BLOOD;
CORONARY ARTERY DISEASE;
DRUG ADMINISTRATION ROUTE;
DRUG ANTAGONISM;
DRUG COMBINATION;
ENZYMOLOGY;
METHODOLOGY;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
BIOLOGICAL MARKERS;
CORONARY ARTERY DISEASE;
CREATINE KINASE, MB FORM;
DRUG ADMINISTRATION ROUTES;
DRUG THERAPY, COMBINATION;
HUMANS;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
RESEARCH DESIGN;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 58149261722
PISSN: 15221946
EISSN: 1522726X
Source Type: Journal
DOI: 10.1002/ccd.21784 Document Type: Note |
|
Times cited : (3)
|
|
References (5)
|
